Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up

por Powles, Thomas, Park, Se Hoon, Caserta, Claudia, Valderrama, Begoña P., Gurney, Howard, Ullén, Anders, Loriot, Yohann, Sridhar, Srikala S., Sternberg, Cora N., Bellmunt, Joaquim, Aragon-Ching, Jeanny B., Wang, Jing, Huang, Bo, Laliberte, Robert J., di Pietro, Alessandra, Grivas, Petros
Publicado 2023